Insider · CIK 0001553599

Flynn Karen

Reports to the SEC for 6 companies · PADUA

sec.gov

Transactions

Companies

Filings

CIK

0001553599

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	STVNStevanato Group S.p.A.S Sale	Director	SSale	−1,493 sh	$17.09	−$25.5K	5,757
2026-06-12	STVNStevanato Group S.p.A.A Award	Director	AAward	+4,975 sh	—	—	7,250
2026-05-22	SHCSotera Health CoA Award	Director	AAward	+15K sh	—	—	54,191
2026-01-02	QTRXQuanterix CorpA Award	Director	AAward	+23.4K sh	—	—	57,212
2025-05-22	SHCSotera Health CoA Award	Director	AAward	+19.1K sh	—	—	39,221
2025-01-02	QTRXQuanterix CorpA Award	Director	AAward	+7,435 sh	—	—	33,840
2025-01-02	QTRXQuanterix Corp · Stock Option (Right to Buy)A Award	Director	AAward	+15.8K sh	—	—	15,821
2024-05-24	SHCSotera Health CoA Award	Director	AAward	+20.1K sh	—	—	20,089
2024-01-02	QTRXQuanterix CorpA Award	Director	AAward	+2,947 sh	—	—	26,405
2024-01-02	QTRXQuanterix Corp · Stock Option (Right to Buy)A Award	Director	AAward	+6,412 sh	—	—	6,412
2023-10-27	Catalent, Inc.A Award	Director	AAward	+6,993 sh	—	—	24,339
2023-01-03	QTRXQuanterix Corp · Stock Option (Right to Buy)A Award	Director	AAward	+12.1K sh	—	—	12,124
2023-01-03	QTRXQuanterix CorpA Award	Director	AAward	+8,083 sh	—	—	22,540
2023-01-03	QTRXQuanterix CorpA Award	Director	AAward	+918 sh	$12.86	+$11.8K	23,458
2022-10-27	Catalent, Inc.A Award	Director	AAward	+4,149 sh	—	—	17,346
2022-10-03	QTRXQuanterix CorpA Award	Director	AAward	+1,066 sh	$10.48	+$11.2K	14,457
2022-09-15	Catalent, Inc.A Award	Director	AAward	+245 sh	—	—	13,197
2022-07-01	QTRXQuanterix CorpA Award	Director	AAward	+164 sh	$16.79	+$2,753.56	13,391
2022-06-06	QTRXQuanterix CorpA Award	Director	AAward	+13.2K sh	—	—	13,227
2022-06-06	QTRXQuanterix Corp · Stock Option (right to buy)A Award	Director	AAward	+19.8K sh	—	—	19,841
2022-01-10	Catalent, Inc.S Sale	Director	SSale	−2,472 sh	$116.64	−$288K	33,223
2021-07-26	Catalent, Inc.Options to purchase Common StockA Award	Director	AAward	+5,953 sh	—	—	5,953
2021-07-26	Catalent, Inc.A Award	Director	AAward	+1,151 sh	—	—	35,695
2021-01-11	Catalent, Inc.S Sale	Director	SSale	−1,100 sh	$112.50	−$124K	34,544
2021-01-11	Catalent, Inc.S Sale	Director	SSale	−1,378 sh	$112.14	−$155K	35,644
2021-01-04	Catalent, Inc.S Sale	Director	SSale	−99 sh	$104.42	−$10.3K	37,022
2020-07-30	Catalent, Inc.Options to purchase Common StockA Award	Director	AAward	+8,005 sh	—	—	8,005
2020-07-30	Catalent, Inc.A Award	Director	AAward	+1,476 sh	—	—	37,121
2020-04-09	Catalent, Inc.A Award	Director	AAward	+359 sh	$56.46	+$20.3K	35,645
2020-01-08	Catalent, Inc.A Award	Director	AAward	+35.3K sh	—	—	35,286
2019-12-05	Societal CDMO, Inc.A Award	Director	AAward	+11.1K sh	—	—	39,283
2019-05-09	Societal CDMO, Inc.Stock Option (right to buy)A Award	Director	AAward	+10.9K sh	—	—	10,888
2019-05-09	Societal CDMO, Inc.A Award	Director	AAward	+7,955 sh	—	—	28,212
2019-02-19	WSTWEST PHARMACEUTICAL SERVICES INC · Stock Options (Right to buy)A Award	Sr VP & Chief Commercial Offic	AAward	+14.3K sh	$102.51	+$1.46M	14,280
2019-02-19	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Sr VP & Chief Commercial Offic	AAward	+2,099 sh	$102.51	+$215K	23,692.148
2018-08-07	WSTWEST PHARMACEUTICAL SERVICES INC · Stock Options (Right to Buy)M Exercise/Conversion	Sr VP & Chief Commercial Offic	MExercise/Conversion	−11K sh	—	—	20,982
2018-08-07	WSTWEST PHARMACEUTICAL SERVICES INCS Sale	Sr VP & Chief Commercial Offic	SSale	−20.5K sh	$116.23	−$2.38M	21,593.148
2018-08-07	WSTWEST PHARMACEUTICAL SERVICES INCM Exercise/Conversion	Sr VP & Chief Commercial Offic	MExercise/Conversion	+11K sh	$25.14	+$277K	42,051.148
2018-08-07	WSTWEST PHARMACEUTICAL SERVICES INCM Exercise/Conversion	Sr VP & Chief Commercial Offic	MExercise/Conversion	+9,458 sh	$21.22	+$201K	31,051.148
2018-08-07	WSTWEST PHARMACEUTICAL SERVICES INC · Stock Options (Right to Buy)M Exercise/Conversion	Sr VP & Chief Commercial Offic	MExercise/Conversion	−9,458 sh	—	—	0
2018-05-12	Societal CDMO, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−13.3K sh	—	—	0
2018-05-12	Societal CDMO, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+13.3K sh	—	—	20,257
2018-05-04	Societal CDMO, Inc.Stock Option (right to buy)A Award	Director	AAward	+5,742 sh	—	—	5,742
2018-05-04	Societal CDMO, Inc.A Award	Director	AAward	+6,183 sh	—	—	6,983
2018-05-04	Societal CDMO, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,965 sh	—	—	8,965
2018-02-20	WSTWEST PHARMACEUTICAL SERVICES INC · Stock Options (Right to buy)A Award	Sr VP & Chief Commercial Offic	AAward	+17.5K sh	$89.64	+$1.57M	17,544
2018-02-13	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Sr VP & Chief Commercial Offic	AAward	+3,870 sh	$93.00	+$360K	21,593.148
2017-12-29	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Sr VP & Chief Commercial Offic	AAward	+7.484 sh	$98.67	+$738.446	17,723.148
2017-12-01	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Sr VP & Chief Commercial Offic	AAward	+7.451 sh	$99.11	+$738.459	1,297.503
2017-11-17	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Sr VP & Chief Commercial Offic	AAward	+7.462 sh	$98.96	+$738.459	1,290.052

Recent filings

Accepted (ET)
Jun 264
Flynn Karen0001193125-26-283788
SEC(opens sec.gov)
May 274
Flynn Karen0001193125-26-242231
SEC(opens sec.gov)
Jan 64
Flynn Karen0001553599-26-000001
SEC(opens sec.gov)
May 274
Flynn Karen0000950170-25-077814
SEC(opens sec.gov)
Jan 64
Flynn Karen0001562180-25-000202
SEC(opens sec.gov)
May 294
Flynn Karen0000950170-24-066037
SEC(opens sec.gov)
Jan 44
Flynn Karen0001562180-24-000232
SEC(opens sec.gov)
Oct 314
Flynn Karen0001596783-23-000153
SEC(opens sec.gov)
Jan 44
Flynn Karen0001562180-23-000102
SEC(opens sec.gov)
Oct 314
Flynn Karen0001596783-22-000169
SEC(opens sec.gov)
Oct 54
Flynn Karen0001562180-22-007044
SEC(opens sec.gov)
Sep 194
Flynn Karen0001596783-22-000142
SEC(opens sec.gov)
Jul 64
Flynn Karen0001562180-22-005558
SEC(opens sec.gov)
Jun 144
Flynn Karen0001562180-22-005091
SEC(opens sec.gov)

Companies

Address

VIA MOLINELLA 17 PIOMBINO DESE

PADUA, 35017